Half Year Results 

Mercia Tech: shares still trail NAV

Mercia Tech: shares still trail NAV

Over the half year to September, the value of Mercia Technologies’ (MERC) direct investment portfolio rose by 17.7 per cent to £77.8m. This stemmed partly from the group’s decision to plough £11.2m into 11 companies, and partly from a £2.6m rise in net fair value gains. Indeed, four portfolio constituents enjoyed uplifts – Faradion, Intechnica, Voxpopme and The Native Antigen Company. These performances were tempered by Aim-traded Concepta (CPT), whose share price fell despite a successful placing and “continuing commercial progress”.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now